FXR agonist 13
FXR agonist 13 is a selective, orally active, potent FXR agonist (EC50 = 0.097 μM) and has favorable hepatic microsomal metabolic stability. FXR agonist 13 exhibits moderate affinity for FXR-LBD upon direct binding (KD = 14.74 μM) . FXR agonist 13 displays good selectivity against related nuclear receptors, including LXRα/β, PPARα/γ/δ, PXR, and TGR5. FXR agonist 13 can be used for the study of metabolic-associated steatohepatitis (MASH) [1].
Product Specifications
Target
FXR
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
O=C(C1=CC=C(C=C1)CN(C(C2=NN(C3=C2C=CC=C3Cl)CCC(F)(F)F)=O)CC4=CC(F)=CC=C4)O
Molecular Formula
C26H20ClF4N3O3
Molecular Weight
533.90
References & Citations
[1]Shi DY, et al. Discovery of novel potent indazole-based FXR agonists via scaffold hopping for MASH treatment. Eur J Med Chem. 2026 Jan 5;301:118203.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA723444 100 µL
Mouse/Rat Factor XII Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
